- Home
- TVRD vs MMT Comparison
TVRD vs MMT Comparison
Compare TVRD & MMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVRD
- MMT
- Stock Information
- Founded
- TVRD 2017
- MMT 1987
- Country
- TVRD United States
- MMT United States
- Employees
- TVRD N/A
- MMT N/A
- Industry
- TVRD Biotechnology: Pharmaceutical Preparations
- MMT Trusts Except Educational Religious and Charitable
- Sector
- TVRD Health Care
- MMT Finance
- Exchange
- TVRD Nasdaq
- MMT Nasdaq
- Market Cap
- TVRD 246.5M
- MMT 262.6M
- IPO Year
- TVRD N/A
- MMT N/A
- Fundamental
- Price
- TVRD $6.73
- MMT $4.78
- Analyst Decision
- TVRD Buy
- MMT
- Analyst Count
- TVRD 7
- MMT 0
- Target Price
- TVRD $51.67
- MMT N/A
- AVG Volume (30 Days)
- TVRD 467.6K
- MMT 86.5K
- Earning Date
- TVRD 11-21-2025
- MMT 01-01-0001
- Dividend Yield
- TVRD N/A
- MMT 8.58%
- EPS Growth
- TVRD N/A
- MMT N/A
- EPS
- TVRD N/A
- MMT 0.30
- Revenue
- TVRD N/A
- MMT N/A
- Revenue This Year
- TVRD N/A
- MMT N/A
- Revenue Next Year
- TVRD N/A
- MMT N/A
- P/E Ratio
- TVRD N/A
- MMT $15.33
- Revenue Growth
- TVRD N/A
- MMT N/A
- 52 Week Low
- TVRD $5.65
- MMT $4.04
- 52 Week High
- TVRD $43.65
- MMT $4.70
- Technical
- Relative Strength Index (RSI)
- TVRD 20.91
- MMT 50.94
- Support Level
- TVRD $5.65
- MMT $4.72
- Resistance Level
- TVRD $7.11
- MMT $4.83
- Average True Range (ATR)
- TVRD 2.47
- MMT 0.04
- MACD
- TVRD -4.16
- MMT -0.00
- Stochastic Oscillator
- TVRD 3.26
- MMT 43.94
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.
About MMT MFS Multimarket Income Trust
MFS Multimarket Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests a majority of its net assets in fixed-income securities, corporate bonds of the U.S and foreign issuers, U.S Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S and foreign issuers, and debt instruments of issuers located in emerging market countries. The portfolio of investments comprises of different sector investments such as aerospace, airlines, automotive, chemicals, electronics, and others.